Abstract:Background: Humanization of mouse monoclonal antibodies (mAbs) is crucial for reducing their immunogenicity in humans. However, humanized mAbs often lose their binding affinities. Therefore, an in silico humanization method that can prevent the loss of the binding affinity of mAbs is needed. Methods: We developed an in silico V(D)J recombination platform in which we used V(D)J human germline gene sequences to design five humanized candidates of anti-tumor necrosis factor (TNF)-α mAbs (C1-C5) by using different human germline templates. The candidates were subjected to molecular dynamics simulation. In addition, the structural similarities of their complementarity-determining regions (CDRs) to those of original mouse mAbs were estimated to derive the weighted interatomic root mean squared deviation (wRMSDi) value. Subsequently, the correlation of the derived wRMSDi value with the half maximal effective concentration (EC50) and the binding affinity (KD) of the humanized anti-TNF-α candidates was examined. To confirm whether our in silico estimation method can be used for other humanized mAbs, we tested our method using the anti-epidermal growth factor receptor (EGFR) a4.6.1, anti-glypican-3 (GPC3) YP9.1 and anti-α4β1 integrin HP1/2L mAbs. Results: The R2 value for the correlation between the wRMSDi and log(EC50) of the recombinant Remicade and those of the humanized anti-TNF-α candidates was 0.901, and the R2 value for the correlation between wRMSDi and log(KD) was 0.9921. The results indicated that our in silico V(D)J recombination platform could predict the binding affinity of humanized candidates and successfully identify the high-affinity humanized anti-TNF-α antibody (Ab) C1 with a binding affinity similar to that of the parental chimeric mAb (5.13 × 10-10). For the anti-EGFR a4.6.1, anti-GPC3 YP9.1, and anti-α4β1 integrin HP1/2L mAbs, the wRMSDi and log(EC50) exhibited strong correlations (R2 = 0.9908, 0.9999, and 0.8907, respectively). Conclusions: Our in silico V(D)J recombination platform can facilitate the development of humanized mAbs with low immunogenicity and high binding affinities. This platform can directly transform numerous mAbs with therapeutic potential to humanized or even human therapeutic Abs for clinical use.

Optimizing the method for expressing human monoclonal antibodies from a single peripheral blood cell from vaccinated donors

Isolation of human monoclonal antibodies from peripheral blood B cells

High-Throughput Isolation of Immunoglobulin Genes from Single Human B Cells and Expression As Monoclonal Antibodies

Generation of Human Neutralizing Monoclonal Antibodies Against the 2009 Pandemic H1N1 Virus from Peripheral Blood Memory B Lymphocytes.

The rapid generation of recombinant functional monoclonal antibodies from individual, antigen-specific bone marrow-derived plasma cells isolated using a novel fluorescence-based method

Human antibodies from transgenic animals

Identification of HBsAg-specific Antibodies from a Mammalian Cell Displayed Full-Length Human Antibody Library of Healthy Immunized Donor.

High throughput monoclonal antibody generation by immunizing multiple antigens

Humanization of Therapeutic Antibody of One Hepatitis B Virus and Identification of Its Biological Activity

Rapid generation of human recombinant monoclonal antibodies from antibody-secreting cells using ferrofluid-based technology

Isolation of the neutralization ScFvs Against HBV infection from the Immunized Population.

A novel selection strategy for antibody producing hybridoma cells based on a new transgenic fusion cell line

A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies

Human Antibody Production in Transgenic Animals

Generation of human single-chain antibody against PreS1 of hepatitis B virus from large naive phage-display library

Efficient Isolation of Monoclonal Antibodies from Antigen-specific Human Plasmablasts and Memory B Cells from a Pneumococcal Conjugate Vaccinee

Developing a workflow for the isolation of hybridoma cells producing fully human antigen-specific antibodies using a surface IgG detection method

Efficient Acquisition of Fully Human Antibody Genes Against Self-Proteins by Sorting Single B Cells Stimulated with Vaccines Based on Nitrated T Helper Cell Epitopes

Human monoclonal antibody cloning and expression with overlap extension PCR and short DNA fragments

Expression Cloning of Antibodies from Single Human B Cells

Antibody Humanization By A Single Cycle Of Cdr-Grafting